Table 3.
Summary statistics of HV samples (concentration)
| Biomarker | Concentration
|
|
|---|---|---|
| HV with stabilizer | HV without stabilizer | |
| A1M (μg/mL) | 0.92±0.97 | 0.43±0.42* |
| B2M (μg/mL) | 0.03±0.02 | 0.04±0.07 |
| Calbindin (ng/mL) | 21.92±24.10 | 52.73±237.73 |
| Clusterin (μg/mL) | 0.019±0.015 | 0.011±0.018 |
| CTGF (ng/mL) | 0.45±0.21 | 0.19±0.13* |
| Creatinine (mg/dL) | 58.90±33.18 | 103.86±67.08 |
| Cystatin-C (ng/mL) | 26.11±18.51 | 14.29±19.03 |
| GSTα (ng/mL) | 7.11±5.55 | 0.32±0.58* |
| KIM-1 (ng/mL) | 0.18±0.11 | 0.18±0.18 |
| Microalbumin (μg/mL) | 4.11±5.84 | 3.97±6.76 |
| NGAL (ng/mL) | 12.25±14.89 | 15.49±27.82 |
| Osteopontin (ng/mL) | 571.35±404.43 | 453.17±440.69 |
| THP (μg/mL) | 0.80±0.41 | 4.85±4.38* |
| TIMP-1 (ng/mL) | 2.18±2.98 | 1.23±3.82 |
| TFF3 (μg/mL) | 0.19±0.13 | 0.24±0.19 |
| VEGF (pg/mL) | 566.75±539.67 | 313.73±470.04 |
Notes: Mean ± standard deviation.
*
Different from HV with stabilizer (P<0.05).
Abbreviations: A1M, α-1-microglobulin; B2M, β-2-microglobulin; CTGF, connective tissue growth factor; GSTα, glutathione S-transferase α; HV, healthy volunteer; KIM-1, kidney injury marker-1; NGAL, neutrophil gelatinase-associated lipocalin; TFF3, trefoil factor 3; THP, Tamm–Horsfall urinary glycoprotein; TIMP-1, tissue inhibitor of metalloproteinase 1; VEGF, vascular endothelial growth factor.